Root Financial Partners
TEVA icon

Root Financial Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Root Financial Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$33K Buy
+834
New +$29.8K ﹤0.01% 1293
2026
Q2 		– Sell
-714
Closed -$21.5K – 2894
2026
Q1 		$21.5K Buy
714
+45
+7% +$1.45K ﹤0.01% 1287
2025
Q4 		$20.9K Buy
669
+18
+3% +$443 ﹤0.01% 1170
2025
Q3 		$13.2K Buy
+651
New +$11.4K ﹤0.01% 1322

Other funds holding TEVA

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Root Financial Partners's TEVA Position: Q3 2026 in Review

Root Financial Partners opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026: 834 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #1293 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in TEVA as recently as Q1 2026.

Root Financial Partners first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. 477 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Root Financial Partners held 834 shares of Teva Pharmaceutical Industries Limited worth $33K as of Q3 2026.
  • Teva Pharmaceutical Industries Limited was a new Root Financial Partners position in Q3 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1293 holding.
  • Root Financial Partners first reported a position in Teva Pharmaceutical Industries Limited in Q3 2025 and has held it in 4 quarters since.
  • 477 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.